NCT07366840 2026-01-26
BRIGHT
Fudan University
Phase 2/3 Not yet recruiting
Clinical Trials
6 trialsNCT02641847 2024-01-25
TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature
Fudan University
Phase 2/3 Active not recruiting
NCT03674242 2022-08-01
Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)
ERYtech Pharma
Phase 2/3 Terminated
NCT01881230 2019-02-21
tnAcity
Celgene
Phase 2/3 Completed
NCT03423849 2018-02-06
The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy
Shandong Cancer Hospital and Institute
Phase 2/3 Unknown
NCT02213744 2017-01-06
HERMIONE
Merrimack Pharmaceuticals
Phase 2/3 Terminated